March 25, 2020
The US Food and Drug Administration on Tuesday approved the first treatment in the US for the coronavirus that has infected more than 50,000 Americans: blood plasma from people who have cleared the infection.
Blood plasma from recovered COVID-19 patients is rich in antibodies their immune system has developed to fight the infection.
China began using the century-old method to treat its patients last month, and New York Governor Andrew Cuomo announced Monday that plasma would be tested there to treat the sickest of the state’s more than 25,000 coronavirus patients.
The treatment may be the best hope for critically ill COVID-19 patients while scientists work to develop new, specific treatments for the disease and test experimental drugs like chloroquine and remdesivir.
‘…given the public health emergency that the expanding COVID-19 outbreak presents, while clinical trials are being conducted, FDA is facilitating access to COVID-19 convalescent plasma for use in patients with serious or immediately life-threatening COVID-19 infections,’ the agency said in a statement, although officiails acknowledged that it doesn’t work for every disease.
This article was posted: Wednesday, March 25, 2020 at 5:04 am